This inventor holds 3 USPTO granted patents. Top assignees: Jago Research Ag, Skyepharma Ag. Active years: 2001-2006.
Company Filing History:
Years Active: 2001-2006
Title: Thomas Eggimann: Innovator in Pharmacological Inhalation Technology
Introduction
Thomas Eggimann is a notable inventor based in Pratteln, Switzerland. He has made significant contributions to the field of pharmacological inhalation technology, holding a total of three patents. His work focuses on improving the delivery of medication through inhalers, enhancing patient experience and treatment efficacy.
Latest Patents
One of Eggimann's latest patents is an inhaler designed for multiple dosed administration of a pharmacological dry powder. This innovative inhaler features a housing with a mouthpiece and a removable protective cap that covers the mouthpiece prior to use. The mouthpiece can be fitted with or without lip grooves, which assist users in positioning and manipulating the inhaler effectively. The device includes a dosing slide, a carriage, a dosing cavity, and a valve shield, all arranged within the housing. Upon removal of the protective cap, dosing is initiated, allowing a dose of pharmacological dry powder to be received in the dosing cavity and transported to the mouthpiece via the dosing slide. The release of the dose for inhalation occurs only when a defined minimum intensity of inhalation is applied, activating the shutter moved by the suctioned valve shield.
Career Highlights
Throughout his career, Thomas Eggimann has worked with various companies, including Jago Research AG and Skyepharma AG. His experience in these organizations has contributed to his expertise in the development of inhalation devices and pharmacological delivery systems.
Collaborations
Eggimann has collaborated with several professionals in his field, including his coworker Manfred Keller. Their joint efforts have further advanced the technology surrounding inhalation devices.
Conclusion
Thomas Eggimann's innovative work in pharmacological inhalation technology has led to the development of advanced inhalers that improve medication delivery for patients. His contributions are significant in the realm of healthcare and continue to influence the industry positively.